MNKD FY 2016 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$175M

Gross Profit

$125M71.3% margin

Operating Income

$67M38.5% margin

Net Income

$126M71.9% margin

EPS (Diluted)

$1.36

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$79M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$107M

Total Liabilities

$291M

Stockholders' Equity

-$184M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$175M	$0	—
Gross Profit	$125M	-$140M	+188.8%
Operating Income	$67M	-$345M	+119.5%
Net Income	$126M	-$368M	+134.1%